eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 05/05/2011
SPC Boots Cream of Magnesia BP


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Cream of Magnesia BP


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient

% w/v

Light magnesium oxide

5.98

Magnesium sulphate

0.075


Go to top of the page
3. PHARMACEUTICAL FORM

A white emulsion.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the relief of indigestion and constipation.


Go to top of the page
4.2 Posology and method of administration

As an antacid

Adults and children over 12 years: 5 to 10ml (1 to 2 teaspoonfuls)

Children 6 to 12 years: 2.5 to 5 ml (0.5 to 1 teaspoonful) according to age.

These doses should be taken in a little water after meals or when required.

Elderly: Dosage may need to be reduced.

As a laxative

Adults and children over 12 years: 25 to 50ml (5 to 10 teaspoonfuls).

Children 6 to 12 years: 5 to 15ml (1 to 3 teaspoonfuls) according to age.

These doses should be taken in a little warm water at bedtime.

Children up to 6 years: As recommended by the doctor.

Elderly: Dosage may need to be reduced.

For oral administration.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

Caution should be exercised in the elderly and in patients with renal impairment.

Laxatives should not be taken where there is severe abdominal pain or used regularly for prolonged periods, except on medical advice.

If symptoms persist consult your doctor.

Keep all medicines out of the reach of children.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Cream of magnesia may interfere with the absorption of cimetidine, diflunisal, digoxin, indomethacin, iron salts and tetracyclines. Absorption of buffered or enteric coated aspirin is increased by simultaneous administration of antacids. Blood concentrations of salicylates will be reduced by antacid-induced changes in urinary pH, increasing urinary excretion.


Go to top of the page
4.6 Pregnancy and lactation

There is no adequate human data from the use of magnesium oxide and magnesium sulphate in pregnant women.

Studies in animals have not been done.

Caution should therefore be exercised when taken by pregnant women.

Although some magnesium may be secreted in breast milk, the concentration is too small to be harmful.


Go to top of the page
4.7 Effects on ability to drive and use machines

No adverse effects known.


Go to top of the page
4.8 Undesirable effects

May cause diarrhoea. In patients with impaired renal function there may be sufficient accumulation of magnesium to produce toxic effects.


Go to top of the page
4.9 Overdose

Symptoms of overdosage include gastrointestinal irritation and watery diarrhoea. Severe poisoning may produce hypermagnesaemia, symptoms of which include nausea, vomiting, flushing, thirst hypotension, drowsiness, confusion, loss of tendon reflexes, muscle weakness, respiratory depression, cardiac arrhythmias, coma and cardiac arrest.

Treatment consists of intravenous administration of calcium gluconate injection 10% in a dose of 10-20ml to counteract respiratory depression or heart block if renal function is normal, adequate fluids should be given to assist removal of magnesium from the body. Dialysis may be necessary in patients with renal impairment or severe hypermagnesaemia.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Magnesium hydroxide has antacid and laxative properties.

Magnesium sulphate has saline laxative properties.


Go to top of the page
5.2 Pharmacokinetic properties

Magnesium hydroxide reacts rapidly with gastric acid to form magnesium chloride. Approximately 15-30% of the magnesium chloride formed is absorbed from the small intestine and is rapidly excreted by the kidneys in patients with normal renal function. Approximately 15-30% of an orally administered dose of magnesium sulphate is absorbed from the small intestine.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Chloroform

Purified water


Go to top of the page
6.2 Incompatibilities

None stated.


Go to top of the page
6.3 Shelf life

36 months.


Go to top of the page
6.4 Special precautions for storage

Protect from freezing.


Go to top of the page
6.5 Nature and contents of container

A white or amber glass bottle having an aluminium pilfer-proof cap with flowed-in PVC liner or an expanded polyethylene liner or with an unlined polypropylene cap.

Pack size: 200, 500ml

Amber glass winchester having a thermoset plastic cap with a steran faced pulpboard liner.

Pack size: 2000 ml


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0014/5304R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

22 August 1990


Go to top of the page
10. DATE OF REVISION OF THE TEXT

September 2002



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/11251/SPC/


Active Ingredients/Generics

 
   magnesium oxide light
   magnesium sulphate